日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial

一项初步随机临床试验表明,缓释型骨化二醇可使血液透析患者的 1,25-二羟基维生素 D 水平恢复正常,并预防继发性甲状旁腺功能亢进症的进展。

Bishop, Charles W; Ashfaq, Akhtar; Choe, John; Strugnell, Stephen A; Johnson, Laura L; Norris, Keith C; Sprague, Stuart M

Incorporation of Calcimimetics into End-Stage Kidney Disease Bundle: Changes in Etelcalcetide Utilization and Parathyroid Hormone Control following End of Transitional Drug Add-On Payment Adjustment Designation

将拟钙剂纳入终末期肾病治疗方案:过渡期药物附加支付调整指定结束后,依替卡西肽使用量和甲状旁腺激素控制的变化

Karaboyas, Angelo; Zhao, Junhui; Ma, Junjie; Moore, Carol; Saleem, Najma; Martin, Kevin J; Sprague, Stuart M; Smerdon, Caroline; Pecoits-Filho, Roberto; Pisoni, Ronald L

Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial

在一项随机试验中,辅助使用活性维生素D治疗非透析慢性肾脏病患者的继发性甲状旁腺功能亢进症时,缓释骨化二醇会降低肾功能。

Ashfaq, Akhtar; Choe, John; Strugnell, Stephen A; Patel, Nilay; Sprague, Stuart M; Norris, Keith C; Lerma, Edgar; Petkovich, P Martin; Bishop, Charles W; Ashfaq, Akhtar

Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?

慢性肾病患者维生素D代谢紊乱的管理:是时候更新传统观念了吗?

Bishop, Charles W; Ashfaq, Akhtar; Choe, John; Norris, Keith C; Sprague, Stuart M

A Perfect Match: 21 Bases to Silence MicroRNA-21

完美匹配:21个碱基沉默microRNA-21

Song, Ryan M; Sprague, Stuart M; Song, Chunzi; Lakhia, Ronak

Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis

在血液透析第一年内,使用蔗糖铁氧氢氧化物作为一线磷酸盐结合剂进行血清磷管理

Medaura, Juan A; Zhou, Meijiao; Ficociello, Linda H; Anger, Michael S; Sprague, Stuart M

Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study

替那帕诺治疗维持性透析患者高磷血症:OPTIMIZE 研究的结果

Sprague, Stuart M; Weiner, Daniel E; Tietjen, David P; Pergola, Pablo E; Fishbane, Steven; Block, Geoffrey A; Silva, Arnold L; Fadem, Stephen Z; Lynn, Robert I; Fadda, George; Pagliaro, Lynae; Zhao, Suling; Edelstein, Susan; Spiegel, David M; Rosenbaum, David P

Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with CKD

肾脏功能磁共振成像生物标志物与慢性肾脏病患者炎症标志物的相关性

Trujillo, Jacquelyn; Alotaibi, Manal; Seif, Nay; Cai, Xuan; Larive, Brett; Gassman, Jennifer; Raphael, Kalani L; Cheung, Alfred K; Raj, Dominic S; Fried, Linda F; Sprague, Stuart M; Block, Geoffrey; Chonchol, Michel; Middleton, John Paul; Wolf, Myles; Ix, Joachim H; Prasad, Pottumarthi; Isakova, Tamara; Srivastava, Anand

Quantitative Blood Oxygenation Level Dependent Magnetic Resonance Imaging for Estimating Intra-renal Oxygen Availability Demonstrates Kidneys Are Hypoxemic in Human CKD

定量血氧水平依赖性磁共振成像评估肾内氧可用性表明,人类慢性肾脏病患者肾脏存在低氧血症

Prasad, Pottumarthi V; Li, Lu-Ping; Hack, Bradley; Leloudas, Nondas; Sprague, Stuart M

Response to Alkali Administration in Women and Men With and Without CKD

慢性肾脏病患者和非慢性肾脏病患者对碱性药物治疗的反应

Pao, Alan C; Shahzad, Sheikh R; Song, Shen; Ganesan, Calyani; Conti, Simon; Leppert, John; Cheung, Alfred K; Ix, Joachim H; Isakova, Tamara; Wolf, Myles; Raj, Dominic S; Sprague, Stuart M; Fried, Linda F; Gassman, Jennifer; Fong, Peter; Koike, Seiji; Raphael, Kalani L